Spasticity-Plus syndrome in multiple sclerosis patients in a tertiary hospital in Spain

ConclusionSpasticity-Plus syndrome was present in all the study population of patients with different MS phenotypes, and treated with nabiximols.
Source: Frontiers in Neurology - Category: Neurology Source Type: research